Anu Lala (Anuradha Lala-Trindade)
@dranulala
Followers
13K
Following
32K
Media
696
Statuses
7K
Mother/wife/daughter. 💜Function cardiologist. @JCardFail Co-EIC. HF Fellowship PD @MountSinaiNYC; #IntegrativeMedicine; in pursuit of more #SelfAwareness
New York, NY
Joined November 2017
Wow. What a journey. And a blessing! 🙏🏽💜 Thank you for allowing us to serve our community in this way. People > IF But nice when IF ⬆️ too 😊 @robmentz @HFSA
People. Experience. Community. Since 2020, it's been how we measure impact at JCF. When numbers reflect our mission, it's even sweeter 💜 🎉 JCF’s 2024 Impact Factor is ⬆️ 8.2 (from 6.7 in 2023) 🫀 Watch how we’re making a difference ⬇️ @Hfsa @robmentz @dranulala
1
12
58
Calling all #FunctionNotFailure peeps 📢 Submit your ⭐️science in special populations: amyloid, sarcoidosis, myocarditis, & other infiltrative & inflammatory cardiomyopathies @JCardFail before December 8!!!! @robmentz @noshreza @AndrewJSauer @TomCascinoMD @heartofthemater
Deadline Approaching! Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue. Explore Topics: https://t.co/pIFbsqRdrR 📆Deadline: Dec. 8, 2025 #CardioTwitter #HeartFailure #CardiologyResearch
0
3
10
Deadline Approaching! Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue. Explore Topics: https://t.co/pIFbsqRdrR 📆Deadline: Dec. 8, 2025 #CardioTwitter #HeartFailure #CardiologyResearch
0
7
11
💡 CABG or PCI? A new perspective on value in ischemic cardiomyopathy. A new #JCFIntersections study on cost-effectiveness analysis comparing CABG + OMT vs PCI + OMT is here. 🔗 Read in Journal of Cardiac Failure – Intersections: https://t.co/NpsE145Wuk
#HeartFailure
1
4
8
Lots of confusion about menopausal hormone therapy right now —who should get it, when to start, and what is the🫀 risk? Our new review led by @BrighamMedRes Ruby Guo covers timing, route, and CV risk stratification for midlife women. 🔗: https://t.co/XCHqVM9tqx
8
40
137
🎧 Our new Podcast episode is live! This week on Heart of the Matter, @coconnormd hosts an incredible panel @MelvinEchols9, @dranulala, @mrchrtfaildoc to dive into the real models of success behind site-based research. Tune in now on YouTube, Spotify, or Apple Podcasts!
0
4
9
In this VA study, the rates of early 🫀follow-up after HFH were low overall & were only modestly associated w/mortality risk at discharge. Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH! 🔗 https://t.co/WN1zwIny5j 🧵
2
2
8
🖥️AI can play a key role in prevention, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias need to be addressed. Learn more in this Review: https://t.co/cBUhh1cGap
2
7
11
NEW | #RCParallax by Dr @AnkurKalraMD Ep146! "The Heart Function Revolution: Why Prevention Matters at Every Stage of Disease" 🎙️ This week's guests are @DrMarthaGulati and @dranulala who outline why prevention must span every stage of heart failure 🎧 Listen here 👉
0
4
5
What a great opportunity for all interested in #CVprev! Led by @PamelaBMorris and @ACCinTouch
#CardioTwitter I love seeing such programs be developed. Things our generation only dreamed of, now becoming real!
📢 Call For Applications: Fuster Prevention Forum The Fuster Prevention Forum aims to equip clinicians with a strong scientific foundation in primordial prevention and evidence supporting early-life interventions. Learn more & submit your application ➡️ https://t.co/SmBPC1JsJE
1
4
24
Semaglutide (Ozempic) failed to have clinical impact for slowing progression in people with mild Alzheimer’s disease in 2 large, placebo-controlled trials https://t.co/NioLZxVad2
38
168
654
Biomarkers of brain inflammation improved. There is still hope GLP-1 drugs may help prevent this dreaded disease. Prevent ≠ Treatment
7
13
128
🚨 Check out this update to 2023 Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP to learn how to maximize the use of natriuretic peptides to guide evidence-based treatment & prevention of HF. 🖇️ https://t.co/7jkIhyg7Zr
0
8
9
Perception based on comparison is never absolute – it is a distortion of Reality. #SadhguruQuotes
121
735
2K
💡HFpEF represents a major clinical challenge, with women up to 2x more likely to be affected. The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women. 🖇️ https://t.co/CjX7xJhO9Z
3
13
46
Our @MountSinaiHeart fellow of the month and @cardionerd @a_radakrishnan led this 🤩 @JCardFail & @AJPCardio SOTA reviewing nuances of incidence & prevention of HFpEF in women with special review of impact of hormonal changes across a woman’s lifespan 🙏🏽@DrMarthaGulati @DLBHATTMD
💡HFpEF represents a major clinical challenge, with women up to 2x more likely to be affected. The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women. 🖇️ https://t.co/CjX7xJhO9Z
1
12
63
New in @JACCJournals: #HFC members @coconnormd, @robmentz, and colleagues report sex differences in the response to a multidomain rehabilitation intervention among patients hospitalized with acute decompensated HF. #HeartFailure #RehabHF
https://t.co/WyiE71mbox
0
3
13
Excited to share that I’ve joined Roon as a Founding Physician. Roon is a new digital home for doctors – a place for real-time clinical insights, honest discussion, and community with colleagues who are navigating the same challenges at the bedside and in our health systems.
4
3
31
Where do 🩺👩🏽⚕️👨⚕️have a home to discuss & share info? 🤔 This very question led me to join Roon as a Founding Physician. Clinical conversations are scattered across platforms that weren’t built for medical communities and most AI tools stop at the published literature, missing
2
7
36
An 89-year-old woman with severe tricuspid regurgitation presented with fever and cough after a recent diagnosis of influenza. Prominent forehead venous pulsations were noted on examination. Read the full case details in the Images in Clinical Medicine article “Forehead Venous
10
171
642
“Melatonin—> 90% ⬆️ risk for heart failure!? “ 🤯 Not so fast. This is an ABSTRACT using TriNetX data- would be super careful in saying patients are “matched” - this is an ASSOCIATION that is wrought with residual confounding. Patients with insomnia may be at higher risk - by
Melatonin linked to alarming rise in heart failure risk: Study A new study has found that long term use of melatonin supplements, often taken for better sleep may be linked to a 90% higher risk of heart failure and nearly double the risk of death compared to non-users.
8
17
81